Aside from ANXA2 and ANXA6, other ANXA family proteins can be used as markers of tumour occurrence and development as they affect a variety of signal pathways, such as cancer cell invasion, migration, apoptosis and autophagy. This evidence concerns the gene ANXA2 and cancer.